https://www.selleckchem.com/pr....oducts/bromelain.htm
There was no difference between insulin-treated DM and noninsulin-treated DM (HR 1.09, 95% CI 0.82-1.46). Stratification by coronary artery disease yielded comparable risk estimates. In patients with AF, DM increases the risk of ischemic stroke, regardless of treatment. In patients with AF, DM increases the risk of ischemic stroke, regardless of treatment. The G-protein-coupled apelin receptor and its apelin ligand are an emerging regulatory system of the vascular homeostasis. To date, the implications of the apelin/apelin receptor sy
Like
Comment
Share
